Prostate Cancer Health Center
Prostate Cancer Risk Factors
All men are at risk for developing prostate cancer. About one man in six will be diagnosed with prostate cancer during his lifetime, but only one man in 34 will die of this disease. About 80 percent of men who reach age 80 have prostate cancer. Besides being male, there are other factors, such as age, race, and family history that may contribute to the risk. These include:
Age. The greatest risk factor for prostate cancer is age. This risk increases significantly after the age of 50 in white men who have no family history of the disease and after the age of 40 in black men and men who have a close relative with prostate cancer. About two-thirds of all prostate cancers are diagnosed in men age 65 and older.
Family history: Men whose relatives have had prostate cancer are considered to be at high risk. Having a father or brother with the disease more than doubles your risk for prostate cancer, according to the American Cancer Society. Having a brother with prostate cancer appears to increase your risk more than having an affected father does. That risk is even higher when there are multiple family members affected. Screening for prostate cancer should be started at age 40 in these men.
Studies have identified several inherited genes that appear to increase prostate cancer risk. Testing for these genes is not yet available. Experts estimate that the hereditary form of prostate cancer accounts for just 5-10% of all cases.
Race: Prostate cancer occurs about 60% more often in African American men than in white American men and when diagnosed is more likely to be advanced. However, Japanese and African males living in their native countries have a low incidence of prostate cancer. Rates for these groups increase sharply when they immigrate to the U.S. African Americans are the second group of men for whom prostate cancer testing should begin at age 40.
Some experts theorize that this suggests an environmental connection, possibly related to high-fat diets, less exposure to the sun, exposure to heavy metals such as cadmium, infectious agents, or smoking. To date, the reasons for these racial differences are not understood.
Diet: Research also suggests high dietary fat may be a contributing factor prostate cancer. The disease is much more common in countries where meat and dairy products are dietary staples, compared to countries where the basic diet consists of rice, soybean products, and vegetables.
Eating a diet high in the antioxidant lycopene (found in high levels in some fruits and vegetables, such as tomatoes, pink grapefruit, and watermelon) may lower your risk of developing prostate cancer according to several studies.
Read more about eating healthy foods, especially as related to cancer prevention.
What Are Other Possible Risk Factors?
Sedentary lifestyle: You may be able to reduce your risk for prostate cancer by getting regular exercise and maintaining your optimal weight.
Reviewed by the doctors at The Cleveland Clinic
Urological Institute.
WebMD Medical Reference provided in collaboration with the Cleveland Clinic![]()
Indication
Uroxatral® (alfuzosin HCl 10 mg extended-release tablets) is an alpha1-blocker for the treatment of the signs and symptoms of BPH.
Important Safety Information
Do not take UROXATRAL if you have liver problems or if you are taking antifungal drugs like ketoconazole or itraconazole, or HIV drugs like ritonavir.
UROXATRAL can cause a sudden drop in blood pressure, especially when starting treatment. This may lead to fainting, dizziness, and lightheadedness. Do not drive, operate machinery, or do any dangerous activity until you know how UROXATRAL will affect you. This is especially important if you already have a problem with low blood pressure or take medicines to treat high blood pressure. There may be an increased risk of low blood pressure and fainting when taking UROXATRAL in combination with blood pressure medication or nitrates.
Before taking UROXATRAL, tell your doctor if you have kidney problems.
Also, tell your doctor if you or any family member(s) have or take medications for a rare heart condition known as congenital prolongation of the QT interval.
BPH and prostate cancer can cause the same symptoms. However, UROXATRAL is not a treatment for prostate cancer.
The most common side effects with UROXATRAL are dizziness, upper respiratory tract infection, headache, and tiredness.
Please see UROXATRAL patient information.
Most Popular Stories
- 6 Sex Mistakes Women Make
- 7 Pains You Shouldn't Ignore
- The Truth About Tattoos
- 8 Ways to Boost Your Fertility
- Pictures of Bugs and Their Bite Marks
- 6 Sex Mistakes Men Make
- 10 Surprising Health Benefits of Sex
- Swine Flu: What Are Symptoms of Swine Flu?
- 15 Foods to Help You Lose
- Cosmetic Surgery: Before & After Pics



